中成药2026，Vol.48Issue(1)：91-96,6.DOI:10.3969/j.issn.1001-1528.2026.01.013
清下解胰颗粒早期干预轻中度急性胰腺炎患者的临床疗效
Clinical effects of early intervention of Qingxia Jieyi Granules on patients with mild-to-moderately acute pancreatitis
摘要
Abstract
AIM To investigate the clinical effects of early intervention of Qingxia Jieyi Granules on patients with mild-to-moderately acute pancreatitis.METHODS Sixty-nine patients were randomly assigned into control group(34 cases)for 1-week intervention of conventional treatment,and observation group(35 cases)for 1-week intervention of both Qingxia Jieyi Granules and conventional treatment.The changes in incidence of reanimation,organ dysfunction condition,modified Marshall score,TCM syndrome efficacy and score and serum biochemical indices(D-dimer,C-reactive protein,amylase,lipase)were detected.RESULTS The observation group demonstrated higher total effective rate of TCM syndromes than the control group(P＜0.05),along with lower incidence of reanimation(P＜0.05).After the treatment,the 2 groups displayed improved organ dysfunction condition(P＜0.05),and decreased modified Marshall score,TCM syndrome score and serum biochemical indices(P＜0.05),especially for the observation group(P＜0.05).CONCLUSION For the patients with mild-to-moderately acute pancreatitis,the early intervention of Qingxia Jieyi Granules can intercept its severity.关键词
清下解胰颗粒/常规治疗/轻中度急性胰腺炎/早期干预/重症化Key words
Qingxia Jieyi Granules/conventional treatment/mild-to-moderately acute pancreatitis/early intervention/severity分类
医药卫生引用本文复制引用
江雨洁,朱生樑,周秉舵,刘晓文,朱华芳,唐义爽,吴月,刘宇洋,张良,孔婧,王晓素..清下解胰颗粒早期干预轻中度急性胰腺炎患者的临床疗效[J].中成药,2026,48(1):91-96,6.基金项目
国家自然科学基金资助项目(81973809) （81973809）
上海市中西医临床协作试点建设项目(ZY2018-2020-FWTX-1004) （ZY2018-2020-FWTX-1004）
上海市卫健委-上海市中医药高层次人才引领计划项目[ZY(2021-2023)-0403] （2021-2023）
上海市卫健委-中医药创新团队(2022CX002) （2022CX002）
中国中医科学院科技创新工程(CI2021A01001) （CI2021A01001）
